knowledge -WSS

knowledge

author：leisure time 2025-09-06 04:35:42 - browse：61152

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： What do new weight loss drugs mean for bariatric surgery?

hotspot

WSS

Takeaways from AdvaMed, the largest medical devices conference

Takeaways from AdvaMed, the largest medical devices conference

A fraught question for the kids of Alzheimer’s: Is it coming for us?

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

In science, is the line between industry and academia shifting?

How Long Island became the ‘eugenics capital of the world’

explore

knowledge

focus

Apple is now the first public company to be valued at $3 trillion

Apellis safety probe of eye disease drug centers on injection needle

Sports medicine is finally prioritizing gender equality

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Supreme Court strikes down use of affirmative action

Psilocybin's anti

Medical leaders decry Supreme Court decision on affirmative action

How doctors and nurses shape Google's AI

Apple is now the first public company to be valued at $3 trillion

Why more medical students aren't specializing in primary care

focus

How to make AI work for medicine

A fraught question for the kids of Alzheimer’s: Is it coming for us?

How to make AI work for medicine

Australia’s approach to dialysis celebrates life

Psilocybin's anti

What do new weight loss drugs mean for bariatric surgery?

hotspot

hotspot

hotspot

explore